JOHNSON + JOHNSON DL 1 revenue breakdown overview

JOHNSON + JOHNSON DL 1 revenue for the last year amounted to 77.15 B EUR, the most of which — 49.61 B EUR — came from its highest performing source at the moment, Innovative Medicine, the year earlier bringing 49.11 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought JOHNSON + JOHNSON DL 1 42.08 B EUR, and the year before that — 45.39 B EUR.